Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model

doi:10.3748/wjg.v10.i8.1191

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3421)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

310

HTML

2600

Figures (1-6)

306

Tables (1-1)

205

Sum=3421

Apr 15, 2004 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 15, 2004; 10(8): 1191-1197
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1191

Full Size Figure Download Figure

Figure 4 Mouse endostatin levels determined in sera of mice inoculated with murine sarcoma cells. S-180 murine sarcoma cells were inoculated into liver. Seven days later, ELISA determined the endostatin concentration and the results were expressed as mean ± SD of 5 animals (P < 0.05, rAAV-endostatin plus etoposide group versus other groups).

Citation: Hong SY, Lee MH, Kim KS, Jung HC, Roh JK, Hyung WJ, Noh SH, Choi SH. Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model. World J Gastroenterol 2004; 10(8): 1191-1197
URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1191.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1191